Stock Market News
Benchmark Holdings appoints Peter George as chairman
AIM-listed biotech company Benchmark Holdings has appointed Peter George as chairman with immediate effect, replacing Alex Hambro, whose retirement was announced back in January.
Benchmark said George is best known for his achievements as chief executive of global pharmaceutical and services company Clinigen, which he founded in 2010 and grew into close to a £1bn market cap company.
He currently serves as chairman of AIM-listed clinical research provider Ergomed and is also an entrepreneur in residence at Oxford Science Innovations.
CEO Malcolm Pye said: "I am delighted to welcome Peter George to our board as chairman. He has a wealth of experience and a demonstrable track record in delivering shareholder value. I look forward to working closely with him as we continue to drive growth across our organisation."
Prior to Clinigen, George held a number of senior roles in the pharmaceutical and healthcare sectors, including CEO of Penn Pharmaceutical Services. He also co-created Unilabs Clinical Trials International in 1997, which was sold to Icon in 2000.
At 1520 BST, the shares were down 2.9% to 51p.
Benchmark said George is best known for his achievements as chief executive of global pharmaceutical and services company Clinigen, which he founded in 2010 and grew into close to a £1bn market cap company.
He currently serves as chairman of AIM-listed clinical research provider Ergomed and is also an entrepreneur in residence at Oxford Science Innovations.
CEO Malcolm Pye said: "I am delighted to welcome Peter George to our board as chairman. He has a wealth of experience and a demonstrable track record in delivering shareholder value. I look forward to working closely with him as we continue to drive growth across our organisation."
Prior to Clinigen, George held a number of senior roles in the pharmaceutical and healthcare sectors, including CEO of Penn Pharmaceutical Services. He also co-created Unilabs Clinical Trials International in 1997, which was sold to Icon in 2000.
At 1520 BST, the shares were down 2.9% to 51p.
Related share prices |
---|
Benchmark Holdings (BMK) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price